Angiotensin II-generating system in dog and monkey ocular tissues

Clinical and Experimental Pharmacology and Physiology

Volumn 24, Issue 3-4, 1997, Pages 243-248

  Shiota, Naotaka ^a   Saegusa, Yumiko ^a   Nishimura, Kazuo ^a   Miyazaki, Mizuo ^b  

^a OSAKA MEDICAL COLLEGE   (Japan)

^b SANTEN PHARMACEUTICAL CO LTD   (Japan)

Author keywords

Angiotensin II; Angiotensin converting enzyme; Chymase; Dog; Monkey

Indexed keywords

ANGIOTENSIN; CHYMASE; DIPEPTIDYL CARBOXYPEPTIDASE; UREA;

ANIMAL TISSUE; AQUEOUS HUMOR; ARTICLE; CHOROID; DOG; ENZYME ACTIVITY; EYE; MONKEY; NONHUMAN; RETINA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCLERA; VITREOUS BODY;

EID: 0030986080     PISSN: 03051870     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1681.1997.tb01814.x     Document Type: Article

References (47)

1. Schelling P, Fischer H, Ganten D. Angiotensin and cell growth: A link to cardiovascular hypertrophy? J. Hypertens. 1991; 9: 3-15.
2. Dzau VJ. Circulating versus local renin-angiotensin system in cardiovascular homeostasis. Circulation 1988; 77 (Suppl. I): I-1-4.
3. Peach MJ. Renin-angiotensin system: Biochemistry and mechanism of action. Physiol. Rev. 1977; 57: 313-70.
4. Ganten D, Hermann K, Linger T, Lang RE. The tissue renin-angiotensin system: Focus on brain angiotensin, adrenal gland and arterial wall. Clin. Exp. Hypertens. A 1983; 5: 1099-18.
5. Okunishi H, Miyazaki M, Okamura T, Toda N. Different distribution of two types of angiotensin H-generating enzymes in the aortic wall. Biodiem. Biophys. Res. Commun. 1987; 149: 1186-92.
6. Okunishi H, Miyazaki M, Toda N. Evidence for a putatively new angiotensin H-generating enzyme in the vascular wall. J. Hypertens. 1984; 2: 277-84.
7. Okamura T, Okunishi H, Ayajiki K, Toda N. Conversion of angiotensin I to angiotensin II in dog isolated renal artery: Role of two different angiotensin II-generating enzymes. J. Cardiovasc. Pharmacol. 1990; 15: 353-9.
8. Shiota N, Okunishi H, Fukamizu A et al. Activation of two angiotensingenerating systems in the balloon-injured artery. FEES Lett. 1993; 323: 239-42.
9. Okunishi H, Oka Y, Shiota N et al. Marked species-difference in the vascular angiotensin II-forming pathways: Human vs rodents. Jpn. J. Pharmacol. 1993; 62: 207-10.
10. Vartio T, Seppa H, Vaheri A. Susceptibility of soluble and matrix fibronectins to degradation by tissue proteinases, mast cell chymase and cathepsin G. J. Biol. Client. 1981; 256: 471-7.
11. Banovac K, Banovac F, Yang J, Koren E. Interaction of osteoblasts with extracellular matrix: Effect of mast cell chymase. Proc. Soc. Exp. Biol. Med. 1993; 203: 221-35.
12. Banovac K, De Forteza R. The effect of mast cell chymase on extracellular matrix: Studies in autoimmune thyroiditis and in cultured thyroid cells. Int. Arch. Allergy Immunol. 1992; 99: 141-9.
13. Reilly CF, Tewksbury DA, Schechter NM, Travis J. Rapid conversion of angiotensin I to angiotensin II by neutrophil and mast cell proteinases. J. Biol. Chem. 1982; 257: 8619-22.
14. Wypij DM, Nichols JS, Novak PJ et al. Role of mast cell chymase in the extracellular processing of big-endothelin-1 to endothelin-1 in the perfused rat lung. Biochem. PImrmacoI. 1992; 43: 845-53.
15. Caughey GH, Leidig F, Viro NF, Nadel JA. Substance Fand vasoactive intestinal peptide degradation by mast cell tryptase and chymase. J. Plmrmacol. Exp. Then 1988; 244: 133-7.
16. Mizutani H, Schechter N, Lazarus G, Black RA, KupperTS. Rapid and specific conversion of precursor interleukin 1β(IL-1β) to an active IL-1 species by human mast cell chymase. J. Exp. Med. 1991; 174: 821-5.
17. Lees M, Taylor DJ, Woolley DE. Mast cell proteinases activate precursor forms of collagenase and stromelysin, but not of gelatinases A and B. Eur. J. Biochem. 1994; 223: 171-7.
18. Kokkonen JO, Kavanen PT. Proteolytic enzymes of mast cell granules degrade low density lipoproteins and promote their granule-mediated uptake by macrophages vitro. J. Biol. Chem. 1989; 264: 10 749-55.
19. Pejler G, Karlström A. Thrombin is inactivated by mast cell secretory granule chymase. J. Biol. Chem. 1993; 268: 11 817-22.
20. Ferrari-Dileo G, Ryan JW, Rockwood EJ, Davis EB, Anderson DR. Angiotensin-converting enzyme in bovine, feline, and human ocular tissues. Invest. Ophihalmol. Vis. Sei. 1988; 29: 876-81.
21. Igic R, Kojovic V. Angiotensin I converting enzyme (kininase II) in ocular tissues. Exp. Eye Res. 1980; 20: 299-303.
22. Vita JB, Anderson JA, Hulem CD, Leopold IH. Angiotensin-converting enzyme activity in ocular fluids. Invest. Ophihalmol. Vis. Sei. 1981; 20: 255-7.
23. Strittmatter SM, Braas KM, Snyder SH. Localization of angiotensinconverting enzyme in the ciliary epithelium of the rat eye. Invest. Ophihalmol. Vis. Sei. 1989; 30: 2209-14.
24. Ikemoto F, Yamamoto K. Renin-angiotensin system in the aqueous humor of rabbits, dogs and monkeys. Exp. Eye Res. 1978; 27: 723-5.
25. Sramek SJ, Wallow IHL, Tewksbury DA, Brandt CR, Poulsen GL. An ocular renin-angiotensin system. Invest. Ophihalmol. Vis. Sei. 1992; 33: 1627-32.
26. Danser AHJ, Dorpel MA, Deinum J et al. Renin, prorenin, and immunoreactive renin in vitreous fluid from eyes with and without diabetic retinopathy. J. Clin. Endocrinol. Metab. 1989; 68: 160-7.
27. Sramek SJ, Wallow IHL, Day RP, Ehrlich EN. Ocular renin-angiotensin: Immunohistochemical evidence for the presence of prorenin in eye tissue. Invest. Ophihalmol. Vis. Sei. 1988; 29: 1749-52.
28. Danser AHJ, Derkx FHM, Admiraal PJJ etal. Angiotensin levels in the eye. Invest. Ophihalmol. Vis. Sei. 1994; 35: 1008-18.
29. Lin C, Stone RA, Wax MB. Angiotensin binding sites in rabbit anterior uvea and human ciliary epithelium cells. Invest. Ophihalmol. Vis. Sei. 1990; 31: 147-52.
30. Ferrari-Dileo G, Davis EB, Anderson DR. Angiotensin binding sites in bovine and human retinal blood vessels. Invest. Ophlhalmol. Vis. Sei. 1987; 28: 1747-51.
31. Mallorga P, Babion RW, Sugrue MR Angiotensin II receptors labelled with 'HSar'.Ile'j-AII in albino rabbit ocular tissues. Curr. Eye Res. 1989; 8: 841-9.
32. Miyazaki M, Okunishi H, Nishimura K, Toda N. Vascular angiotensinconverting enzyme activity in man and other species. Clin. Sei. 1984; 66:39-15.
33. Caughey GH, Raymond WW, Vanderslice P. Dog mast cell chymase: Molecular cloning and characterization. Biochemistry 1990; 29: 5166-71.
34. Urata H, Kinoshita A, Perez DM et al. Cloning of the gene and cDNA for human heart chymase. J. Biol. Chem. 1991; 266: 17 173-9.
35. Soubrier F, Alhenc-Gelas F, Hubert C et al. Two putative active centers in human angiotensin I-converting enzyme revealed by molecular cloning. Proc. NatlAcad. Sei. USA 1988; 85: 9386-90.
36. Smelser GK, Silver S. The distribution of mast cells in normal eye. Exp. Eye Res. 1963; 2: 134-40.
37. Levene RZ. Mast cells and amines in normal ocular tissues. Invest. Ophlhalmol 1962; 1: 531-43.
38. Godfrey WA. Characterization of the choroidal mast cell. Trans. Am. Ophlhalmol. Soc. 1987; 85: 557-99.
39. Louden C. Render JA, Carlton WW. Mast cell numbers in normal and glaucomatous canine eyes. Am. J. Vet. Res. 1990; 51: 818-19.
40. Vannas S. Mast cells in glaucomatous eyes. Acta Ophlhalmol. 1959; 37:330-9.
41. Urata H, Boehm KD, Philip A et al. Cellular localization and regional distribution of an angiotensin Il-forming chymase in the heart. J. Clin. Invest. 1993; 91: 1269-81.
42. Urata H, Ganten D. Cardiac angiotensin II formation: The angiotensin-I converting enzyme and human chymase. Eur. Heart J. 1993; 14:177-82.
43. Wintroub BU, Schechter NB, Lazarus GS, Kaempfer CE, Schwanz LB. Angiotensin I conversion by human and rat chymotryptic proteinases. J. Invest. Dermaiol. 1984; 83: 336-9.
44. Studer R, Reinecke H, Müller B, Holtz J, Just H, Drexler H. Increased angiotensin-I converting enzyme gene expression in the failing human heart. J. Clin. Invest. 1994; 94: 301-10.
45. Rockwood FJ, Fantes F, Davis EB, Anderson DR. The response of retinal vasculature to angiotensin. Invest. Ophthalmol. Vis. Sei. 1987; 28: 676-82.
46. Abrams KL, Brooks DE, Laratta LJ, Barnhill MA, Frazier D. Angiotensin converting enzyme system in the normal canine eye: Pharmacological and physiological aspects. J. Ocular Phannacol. 1991 ; 7:41-51.
47. Constad WH, Fiore P, Samson C, Cinotti AA. Use of an angiotensin converting enzyme inhibitor in ocular hypertension and primary openangle glaucoma. Am. J. Ophthalmol. 1988; 105: 674-7.